---
content_type: page
description: This section provides information about each of the video webinars offered
  when the course ran live.
learning_resource_types: []
ocw_type: CourseSection
title: Calendar
uid: 2c792bd7-4590-5d33-6e50-77b0ae1237e1
---

Note: The guest speakers are among the leading scientists in diverse areas relevant to COVID-19. Some of these scientists are employed by biopharmaceutical companies; the selection of these speakers is not meant as an endorsement of these companies or their products. 

{{< tableopen >}}
{{< theadopen >}}
{{< tropen >}}
{{< thopen >}}
lec #
{{< thclose >}}
{{< thopen >}}
TOPIC & DaTE
{{< thclose >}}
{{< thopen >}}
SPEAKER
{{< thclose >}}

{{< trclose >}}

{{< theadclose >}}
{{< tropen >}}
{{< tdopen >}}
1
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "242d07bb-8a15-45c3-8c09-cbab2fc89587" "COVID-19 and the Pandemic" %}}

9/1/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Bruce D. Walker of the Ragon Institute of MGH, MIT and Harvard
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
2
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "63d5ff1b-5c3c-453b-889a-bb5f6eaeb3b4" "Coronavirus Biology" %}}

9/8/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Britt Glaunsinger ﻿of the University of California, Berkeley 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
3
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "3e00050f-b2e4-417c-988b-005ef4f7c0c9" "Virology and Lessons from the AIDS Pandemic" %}}

9/15/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. David Baltimore of Caltech
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
4
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "3973a1ad-55eb-4710-9e11-ad5fb0cc02c9" "Insights from the COVID-19 Pandemic" %}}

9/22/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID)
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
5
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "dde22feb-39cb-4510-97e1-0a59de51bfb1" "Viral Immunology" %}}

9/29/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Michel Nussenzweig of The Rockefeller University
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
6
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "7f5d07d1-7466-4e2b-8d62-32900588f8cd" "Target Cells and the Innate Response" %}}

10/6/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Shiv Pillai of the Ragon Institute and MGH
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
7
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "77344e6f-c209-4325-84bb-e8ba1a0656d0" "The Patient" %}}

10/20/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Victoria Clark of Whitehead Institute and MGH
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
8
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "e16e57df-7c27-4422-8d7a-c421f3eff39d" "Epidemiology" %}}

10/27/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Michael Mina of the Harvard T. H. Chan School of Public Health
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
9
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "9972aafa-5c25-437a-937d-70aab4f50e0e" "Immunology: T Cells" %}}

11/3/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Arlene Sharpe of Harvard Medical School
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
10
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "c6a2ab88-6331-4383-a8c4-1109aa7e07ac" "Vaccines" %}}

11/10/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Kizzmekia Corbett of the National Institutes of Health
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
11
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "6d7811e3-29ee-4bd2-9cc9-e4e276c5c9f3" "Immunology: Antibodies" %}}

11/17/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Akiko Iwasaki of Yale Medical School
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
12
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "cc4a9da2-f2fb-47bd-b89e-e134266555c0" "Small Molecule Therapeutics" %}}

11/24/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. James Bradner of the Novartis Institutes for BioMedical Research (NIBR)
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
13
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "18099c8c-c6b8-4398-b9b3-0503e02bb548" "Therapeutics Discovery" %}}

12/1/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Skip Virgin of Vir Biotechnology
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
14
{{< tdclose >}}
{{< tdopen >}}


{{% resource_link "0462087a-bf1a-4089-b9a1-3a6c708c2d12" "Rapid Research Response in a Pandemic" %}}

12/6/2020


{{< tdclose >}}
{{< tdopen >}}
Dr. Eric Lander of the Broad Institute of MIT and Harvard
{{< tdclose >}}

{{< trclose >}}

{{< tableclose >}}